title: Tolerability of methotrexate and leflunomide combination therapy for inflammatory arthritis in routine clinical practice: results of a four-centre study.
authors.forename: A
authors.initials: A
authors.lastname: Kaul
authors.forename: D T
authors.initials: DT
authors.lastname: O'Reilly
authors.forename: R K
authors.initials: RK
authors.lastname: Slack
authors.forename: D
authors.initials: D
authors.lastname: Collins
authors.forename: J
authors.initials: J
authors.lastname: Walmsley
authors.forename: O
authors.initials: O
authors.lastname: Duke
authors.forename: P D W
authors.initials: PD
authors.lastname: Kiely
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001168:Arthritis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D000077339:Leflunomide; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged
chemical_list: D018501:Antirheumatic Agents; D007555:Isoxazoles; D000077339:Leflunomide; D008727:Methotrexate